CJC(NO DAC)/IPA 5mg/5mg

CJC‑1295 + Ipamorelin Stack — Overview

The CJC‑1295 + Ipamorelin stack is a two‑peptide research combination commonly used in laboratory settings to study pituitary signaling, growth‑hormone–related pathways, and multi‑peptide receptor interactions. Because each peptide targets different components of the growth‑hormone regulatory system, the combination is frequently examined for its potential synergistic effects in controlled research environments.

Background & Research Interest

This peptide pairing is often studied in research exploring:

• GHRH receptor activation (CJC‑1295)
• Ghrelin receptor activation (Ipamorelin)
• Pituitary signaling dynamics
• Peptide selectivity and receptor specificity
• Comparative and combined peptide behavior
• Structure–activity relationships in multi‑pathway peptide models

Researchers use this combination to observe how peptides with complementary mechanisms behave when studied together.

Component Breakdown

CJC‑1295

A synthetic analog of growth hormone–releasing hormone (GHRH).

Studied for:

• Pituitary signaling pathways
• Peptide stability and half‑life extension (DAC vs. non‑DAC variants)
• Receptor‑binding characteristics

Ipamorelin

A selective ghrelin (GHS‑R1a) receptor agonist and synthetic pentapeptide.

Studied for:

• Targeted receptor activation
• Selective peptide–receptor interactions
• Pituitary‑level biochemical responses

General Characteristics

• Peptide Type: Two‑peptide research blend
• Components: CJC‑1295 + Ipamorelin
• Form: Typically supplied as separate or combined lyophilized powders
• Solubility: Reconstituted in sterile, research‑grade solvents
• Purity: Each component is generally provided at high purity suitable for controlled laboratory research

Storage & Handling

• Store in a cool, dry environment, protected from light
• Keep vials sealed until use
• Handle using standard laboratory safety procedures

For laboratory research only. Not for human consumption.